SCHEMBL31511206

SCHEMBL31511206

COc1cc(C(C)(C)OC)cc(OC)c1SCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
RAB9A P51151 5/20 0.40
MAPT P10636 4/20 0.40
NPSR1 Q6W5P4 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
NPC1 O15118 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
MCL1 Q07820 1/20 0.39
EGFR P00533 2/20 0.39
ELANE P08246 1/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2E1 P05181 1/20 0.39
CYP2C8 P10632 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2B6 P20813 1/20 0.39
CYP2C19 P33261 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31525474 0.80 RAB9A (0.41) ALDH1A1RAB9AMAPTL3MBTL1NPC1
SCHEMBL31650603 0.77 RAB9A (0.43) ALDH1A1RAB9AMAPTNPSR1L3MBTL1
SCHEMBL31650336 0.75 MRGPRX4 (0.49) RAB9AMAPTNPC1SMN1; SMN2LMNA
SCHEMBL31511010 0.73 ALDH1A1 (0.40) ALDH1A1RAB9AMAPTNPSR1L3MBTL1
SCHEMBL31650588 0.73 EGFR (0.45) ALDH1A1RAB9AMAPTNPSR1L3MBTL1
SCHEMBL31649992 0.73 MAPT (0.43) ALDH1A1RAB9AMAPTNPSR1L3MBTL1
SCHEMBL31650484 0.72 SMN1; SMN2 (0.49) ALDH1A1RAB9AMAPTL3MBTL1NPC1
SCHEMBL31650127 0.71 ALOX5 (0.50) ALDH1A1MAPTNPSR1L3MBTL1SMN1; SMN2
SCHEMBL31172708 0.71 RAB9A (0.46) ALDH1A1RAB9AMAPTNPSR1L3MBTL1
SCHEMBL31172733 0.70 NR2E3 (0.49) ALDH1A1RAB9AMAPTNPSR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250276966-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives PFIZER (US) 2025-09-04 US disclosed
US-20250122183-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives PFIZER (US) 2025-04-17 US disclosed
WO-2025074249-A1 NITROGEN-LINKED BENZISOXAZOLE SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF CANCER PFIZER INC. (US) 2025-04-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122183-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives CCNI, MKI67, CCNA1 ALDH1A1 761/4885RAB9A 3079/4885MAPT 4778/4885
US-20250276966-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives CCNI, MKI67, CCNA1 ALDH1A1 792/4885RAB9A 3079/4885MAPT 4791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.